ddp4 inhibitors and glp 1 DPP4 vs GLP-1 Agonists | June 2021 | Clinical Corner Neuroprotection by dipeptidyl-peptidase-4 inhibitors and

Doctors may recommend: Strength training exercises Higher protein intake Calcium and vitamin D monitoring Bone density testing in some patients Lifestyle factors can play a major role in protecting bone health during weight loss

[6] These agents were initially developed for type 2 diabetes management but have demonstrated significant efficacy in weight reduction, leading to their expanded use in obesity treatment

Adverse Effects: Users have reported side effects such as nausea, facial flushing, and spontaneous erections in males

You still feel full after smaller meals

Both are engineered molecules designed to interact with hormones involved in metabolic regulation

Psychiatry 179 , 122131 (2022)